Table 1.
Clinical characteristics
| Variables | LGV group (n=9) | HGV group (n=7) |
|---|---|---|
| Age (years) | 40.2±16.1 | 36.9±18.9 |
| Sex (female/male) | 7/2 | 2/5 |
| T1D duration (years) | 13.8 (3.0–28.0) | 13.0 (3.8–38.0) |
| HbA1c (mmol/mol) | 46.0 (44.5–52.5) | 80.0 (69.0–110.0)* |
| HbA1c (%) | 6.4 (6.3–7.0) | 9.5 (8.5–12.2)* |
| BMI (kg/m2) | 23.9±3.3 | 25.5±2.7 |
| CKD-EPI-GFR (ml/min per 1.73 m2) | 87.3±8.0 | 89.0±2.6 |
| Score on modified Clarke questionnaire | 0 (0–1) | 3 (2–3)* |
|
Severe hypoglycaemic event in past year (events per individual) |
0 | 0.29 |
|
Severe hypoglycaemic event throughout life (events per individual) |
0.11 | 1.29 |
Data are shown as mean±SD, median (IQR) or number
*p<0.05 vs LGV group
CKD-EPI-GFR, Chronic Kidney Disease Epidemiology Collaboration glomerular filtration rate; T1D, type 1 diabetes